share_log

Oragenics Announces Award Of A Grant From CQDM For Development Of A Variant-Agnostic Protein Antigen For Use In Its COVID-19 Intranasal Vaccine Receives

Oragenics Announces Award Of A Grant From CQDM For Development Of A Variant-Agnostic Protein Antigen For Use In Its COVID-19 Intranasal Vaccine Receives

Oragenics 宣佈獲得 CQDM 資助，用於開發用於其 COVID-19 鼻內疫苗的變異無知蛋白抗原
Benzinga ·  2023/06/06 04:20

Oragenics Announces Award Of A Grant From CQDM For Development Of A Variant-Agnostic Protein Antigen For Use In Its COVID-19 Intranasal Vaccine Receives

Oragenics 宣佈獲得 CQDM 資助，用於開發用於其 COVID-19 鼻內疫苗的變異無知蛋白抗原

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論